Care / Nurnberg / Paris / Cleveland / Deutsche Krebsgesellschaft / Hospital Plzen / Western Deanery / Valencia / Universitaria di Modena / Cambridge / London / /
Company
Meteos Limited / GlaxoSmithKline / CZ Healthcare Insurance Group / Bristol Myers Squibb / Johnson & Johnson / Klinikum Offenbach GmbH / Company Health Insurance Funds Italy / Advent Venture Partners / AstraZeneca / /
Continent
Europe / /
Country
Netherlands / France / Japan / United Kingdom / Republic of Italy / Germany / Italy / Sweden / Poland / United States / Spain / Czech Republic / /
Facility
University of York / Institute of Metabolic Science / University of Dundee / Newcastle University / University of Glasgow / National Institute / Pitié-Salpêtrière Hospital / Uppsala University / NHS North Western Deanery / Federal Institute / Paul Ehrlich Institute / University of Pisa School / University Hospital Plzen / Karolinska Institute / University of Nottingham / University of Milan / Kettering Cancer Center / University of Nantes / University of Erlangen-Nuremberg / Tulane University Medical Center / Munich Diabetes Research Institute / Pomeranian Medical University / /
IndustryTerm
stakeholder / healthcare institutions / healthcare costs / health systems / public-private networks / health technology assessment / healthcare systems / healthcare outcomes / healthcare leaders / /
MedicalCondition
breast cancer / Cancer / diabetes / chronic diseases / /
Organization
Genetic Alliance UK / Ruhr-Universität Bochum / National Institute for Clinical Health and Excellence / Dutch Federation of Cancer Patients / European Breast Cancer Coalition / French National Authority for Health / University of Milan / Newcastle University / National Federation / University of Pisa School of Medicine / National Health Service Confederation / Senate of the Republic / Swedish Breast Cancer Association / Pitié-Salpêtrière Hospital / Ministry of Economy / Finance & Industry / Economic Committee for Health Products / Institute of Metabolic Science / Italian Medicines Agency / civil society / National Institute for Health and Clinical Excellence / University of Erlangen-Nuremberg / Dutch Diabetes Association / Economic Committee on Healthcare Products / European Commission / Tulane University Medical Center / European Union / NHS / Federal Joint Committee / National Health Service / Institute for Innovation and Valuation / Pomeranian Medical University / Food and Drug Administration / Investigative Committee on the National Healthcare System / University of York / Federal Institute for Drugs and Medical Devices / Stockholm School of Economics / Medical Products Agency / University of Nantes / Dental and Pharmaceutical Benefits Agency / University of Glasgow / German Centre for Health Technology Assessment and Public Health / Karolinska Institute / Pharmaceutical Benefits Board United Kingdom / Paul Ehrlich Institute / Department of Pharmacy and Health Products / Munich Diabetes Research Institute / European Medicines Agency / HTA Centre / University of Nottingham / Memorial Sloan-Kettering Cancer Center / Transparency Commission Germany / Ministry of Health France / French Health Products Safety Agency / Healthcare Insurance Board / Medicines and Healthcare products Regulatory Agency / University of Dundee / Uppsala University / Ministry of Economy / Service for Manufacturing Industries & Postal Activities / /
Person
Mike Farrar / Ron Cooper / Michael Untch / Pierre-Jean Lancry / Thomas Lönngren / Jan Lubiński / Anders Olauson / Harald Enzmann / Jim Baker / Félix Lobo-Aleu / Mike Richards / Ignazio Marino / Johannes Bruns / Susan Knox / Alan Barge / Eddie Gray / Andrew Morris / EUROPA DONNA / Gunnar Olsson / Anthony Howell / Martin Fitchet / David Byrne / Bert Boer / David Cooksey / Wolfgang Schmeinck / Amanda Adler / David Norton / Mohan Kumar / María Luisa Poncela / Diana Monissen / Harald Klein / Paolo Paoletti / Andrew Briggs / Mike Leers / Bernard Charbonnel / Eric Abadie / Karol Sikora / Karl Claxton / Carlo Russo / Jane Griffiths / Luca Gianni / Pavel Hroboň / Ulf Säther / Ann-Christin Tauberman / Sophia Tickell / John Robertson / Jean-François Bergmann / Peter Kolominsky-Rabas / Carlos III / Pierre Démolis / Michael Rawlins / Andrew Witty / Bruno Angelici / Rainer Hess / Emmanuel Caquot / Noël Renaudin / / /
Position
Deputy Minister / Director for Cancer & End National Clinical / Impartial Chairman / Executive Director / President / Vice President / Europe / Chief Executive / Chief Executive Officer / Member of the Board / Director-General / Head / Director General / CEO / Professor / Executive / Regional Vice President / Deputy Director-General / advisors / Senator & Chair / Chairman / Director / Commissioner / Executive Vice President / Company Group Chairman / Observer / /
Initiative overview EUROPEAN HEALTHCARE INNOVATION LEADERSHIP NETWORK PILOTS OF MULTI-STAKEHOLDER CONSULTATIONS IN DRUG DEVELOPMENT NOVEMBER 2011